科華恆盛(002335.SZ)及子公司合計捐贈200萬元用於新型冠狀病毒肺炎疫情防控工作
格隆匯2月6日丨科華恆盛(002335.SZ)公佈,公司於2020年2月6日召開第八屆董事第三次會議,會議通過了《關於對外捐贈支持抗擊新型冠狀病毒肺炎疫情的議案》,公司董事會同意公司及全資子公司漳州科華技術有限責任公司(“漳州科華技術”)向廈門市紅十字會及漳州市薌城區紅十字會合計捐贈200萬元現金,專用於新型冠狀病毒肺炎疫情防控工作。後續公司將根據抗擊疫情的需求捐贈公司相關產品設備並提供解決方案,全力支持抗擊新型冠狀病毒肺炎疫情,切實履行上市公司社會責任。
公司此次對外捐贈是積極響應國家關於防控新型冠狀病毒肺炎疫情重要指示精神和要求的體現,符合公司積極承擔社會責任的企業文化和創造價值、回報社會的目標宗旨。此次對外捐贈資金來源於公司自有資金,對公司當期及未來經營業績不構成重大影響,亦不存在損害公司和投資者利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.